![Matthew Davis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Davis
Director de Operaciones en TIZIANA LIFE SCIENCES LTD .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Gabriele Cerrone | M | 52 |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 26 años |
John Brancaccio | M | 76 |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 4 años |
Willy Simon | M | 72 |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 9 años |
Martin S. Dorph | M | - |
Temple University (Pennsylvania)
| 29 años |
Richard J. Fox | M | - |
Temple University (Pennsylvania)
| - |
Keeren Shah | F | 47 |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 4 años |
Michael L. Browne | M | 77 |
Temple University (Pennsylvania)
| - |
Tsan Chien Chen | M | - |
Temple University (Pennsylvania)
| - |
Kenneth J. Blank | M | - |
Temple University (Pennsylvania)
| - |
John William Smagula | M | 54 |
Temple University (Pennsylvania)
| 21 años |
Chidiebere Uzoije | M | - |
Temple University (Pennsylvania)
| 25 años |
Bret Perkins | M | - |
Temple University (Pennsylvania)
| - |
Bruce K. Fenton | M | - |
Temple University (Pennsylvania)
| - |
Brian Bollwage | M | - |
Temple University (Pennsylvania)
| - |
Joel C. Rosenfeld | M | - |
Temple University (Pennsylvania)
| - |
Gerard J Criner | M | - |
Temple University (Pennsylvania)
| - |
Vaseem Palejwala | M | - | 7 años | |
Shannon M. Wong | M | - |
Temple University (Pennsylvania)
| - |
Judith Felgoise | F | - |
Temple University (Pennsylvania)
| - |
John Contoudis | M | - |
Temple University (Pennsylvania)
| - |
Edward Rudolph | M | - |
Temple University (Pennsylvania)
| - |
Teresa Soufas | F | - |
Temple University (Pennsylvania)
| - |
Robert Stroker | M | - |
Temple University (Pennsylvania)
| - |
Sandra Harmon-Weiss | F | - |
Temple University (Pennsylvania)
| - |
Paul Rardin | M | - |
Temple University (Pennsylvania)
| - |
Sophia Lee | F | - |
Temple University (Pennsylvania)
| - |
Paul Spencer | M | - | 2 años | |
Kathryn R. Doyle | M | - |
Temple University (Pennsylvania)
| - |
Yuan Shi | M | - |
Temple University (Pennsylvania)
| - |
John Timothy Nosek | M | - |
Temple University (Pennsylvania)
| - |
Jay H. Shah | M | 55 |
Temple University (Pennsylvania)
| - |
Nelson Díaz | M | 76 |
Temple University (Pennsylvania)
| - |
Alan M. Cohen | M | 73 |
Temple University (Pennsylvania)
| - |
Sandra C. Cottrell | M | 75 |
Temple University (Pennsylvania)
| - |
Jon Boscia | M | 71 |
Temple University (Pennsylvania)
| - |
Lonnie Moulder | M | 66 |
Temple University (Pennsylvania)
| - |
Jane Scaccetti | F | 69 |
Temple University (Pennsylvania)
| 17 años |
David R. Devereaux | M | - |
Temple University (Pennsylvania)
| - |
Joseph Coradino | M | 72 |
Temple University (Pennsylvania)
| - |
Reza Fassihi | M | 72 |
Temple University (Pennsylvania)
| 32 años |
Jules S. Jacob | M | - |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | - |
Najib Babul | M | - |
Temple University (Pennsylvania)
| - |
Patrick J. O'Connor | M | - |
Temple University (Pennsylvania)
| - |
Joseph Marshall | M | 71 |
Temple University (Pennsylvania)
| 23 años |
Philip E. Garber | M | - |
Temple University (Pennsylvania)
| - |
Robert Dettery | M | - |
Temple University (Pennsylvania)
| - |
Reese Timothy | M | - |
Temple University (Pennsylvania)
| - |
John J. Friel | M | - |
Temple University (Pennsylvania)
| - |
Sydney D. Finkelstein | M | - |
Temple University (Pennsylvania)
| - |
Joseph Vassalluzzo | M | 75 |
Temple University (Pennsylvania)
| - |
Langley Spurlock | M | - |
Temple University (Pennsylvania)
| - |
Michael E. Lusty | M | 61 |
Temple University (Pennsylvania)
| - |
William Clementi | M | - | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Kunwar Shailubhai | M | 67 |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 14 años |
Hana Malik | M | - |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 9 años |
Neil Graham | M | 65 |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | 1 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 45 | 80.36% |
Bermudas | 11 | 19.64% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Matthew Davis
- Red Personal